![James Cummings](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Cummings
Technik-/Wissenschafts-/F&E-Leiter bei
VAXART, INC.
Vermögen: 279 017 $ am 31.05.2026
Profil
Dr. James F.
Cummings, MD, is a Chief Medical Officer at Vaxart, Inc. Dr. Cummings was previously employed as a President & Chief Executive Officer by ICON Government & Public Health Solutions, Inc., a VP-Clinical Development & Translational Medicine by Novavax, Inc., a Director-Defense Department by Global Emerging Infectious Surveillance & Response System, and a Director-Translational Medicine by Walter Reed Army Institute of Research.
He also served on the board at OyaGen, Inc. He received his undergraduate degree from Georgetown University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VAXART, INC. 0,18 % | 26.05.2026 | 432 585 ( 0,18 % ) | 279 017 $ | 31.05.2026 |
Aktive Positionen von James Cummings
| Unternehmen | Position | Beginn |
|---|---|---|
| VAXART, INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.09.2021 |
Ehemalige bekannte Positionen von James Cummings
| Unternehmen | Position | Ende |
|---|---|---|
ICON Government & Public Health Solutions, Inc.
 ICON Government & Public Health Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research solutions | Vorstandsvorsitzender | 01.09.2021 |
| NOVAVAX, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 |
Global Emerging Infectious Surveillance & Response System | Corporate Officer/Principal | 01.08.2015 |
Walter Reed Army Institute of Research | Corporate Officer/Principal | 01.03.2009 |
OyaGen, Inc.
 OyaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies | Direktor/Vorstandsmitglied | - |
Ausbildung von James Cummings
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
OyaGen, Inc.
OyaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies | Health Technology |
ICON Government & Public Health Solutions, Inc.
ICON Government & Public Health Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research solutions | Commercial Services |
Walter Reed Army Institute of Research | |
Georgetown University School of Medicine
 Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxart, Inc.
 Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
Global Emerging Infectious Surveillance & Response System |
